The use of vectors for gene therapy requires an evaluation of the vector biodistribution during preclinical phases and of the dissemination of the vector during the clinical phases I & II.
Texcell has developed study plans to detect viruses, vectors or specific gene sequences by qPCR in a variety of different samples and fluids (see list below).
- Bones, muscles and joints
- Nerves, spinal chord, pia mater
- Aerial tract
- Gastrointestinal tract
- Urinary tract
- Reproductive system
- Blood, lymph, lymph nodes, heart and vessels
- Adrenal system
For a comprehensive list of tissues, please visit vivo Science, a Texcell company.